WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: FEBRUARY ISSUE PUBLISHED
  • FEBRUARY 2026 Issue has been successfully launched on 1 FEBRUARY 2026.

  • WJPPS: New Impact Factor 2026
  • WJPPS Impact Factor has been Increased to 8.485 for Year 2026.

Abstract

CLINICAL EFFICACY OF SHODHITA KASISADRAVA BASTI IN THE MANAGEMENT OF ARSHA (SECOND-DEGREE INTERNAL HAEMORRHOIDS): A CASE STUDY

Sagar Negi*, Bhabhor Savitribahen, Dr. Darshana Ramole

ABSTRACT

Introduction: Arsha is a common anorectal disorder characterized by swelling of the anal tissues, often associated with pain, bleeding, and prolapse. In Ayurvedic classics, Arsha is described as a Tridoshaja Vyadhi, predominantly involving Apana Vata. Second-degree internal haemorrhoids, which prolapse during defecation and reduce spontaneously are often managed with conservative approaches. The present study explores the efficacy of Shodhita Kasisadrava Basti, a medicated enema using purified Kasisa - as a novel intervention in the management of second-degree internal haemorrhoids (Arsha). Methods: A single case of a 36-year-old male patient presenting with classical signs of second-degree internal haemorrhoids, bleeding per rectum, and prolapse during defecation- was selected based on the diagnostic criteria: Clinical symptoms and Digital per rectalexamination. A total of 9 Basti were administered over 3 weeks (3 consecutive Basti per week), prepared using 5 Ratti(625mg) of Shodhita Kasis Churna dissolved in 30 ml distilled water. The patient was assessed on baseline, weekly intervals, and at a 45-day follow-up post- treatment for symptoms including bleeding, prolapse, itching and discomfort. Results: Marked improvement was observed after the completion of 9 Basti. Bleeding per rectum ceased by the 6th Basti, and prolapse reduced significantly. Discomfort during defecation were alleviated. On 45-day follow-up, the patient reported no recurrence of or prolapse, and digital rectal examination revealed no significant internal bulge. No adverse reactions were noted during or after the intervention. Discussion and Conclusion: The use of Shodhita Kasisadrava Basti demonstrated promising results in reducing the clinical features of second-degree internal haemorrhoids(Arsha). The localized action of Kasisa on the vascular tissues and its Shankochan and Lekhana properties, when administered rectally, may help shrink the pile mass and alleviate symptoms without invasive procedures. This case study supports the potential of Kasisadrava Basti as a minimally invasive and effective Ayurvedic therapy for haemorrhoids, meriting larger clinical trials.

Keywords: Arsha, Shodhita Kasisadrava Basti, Internal Haemorrhoids, Basti Karma.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More